Question-and-Answer Session
Operator
(Operator Instructions) Our first question is coming from Derek Leckow with Barrington Research. Please state your question.
Derek Leckow – Barrington Research
Thank you, good morning.
Joe Capper
Good morning.
Derek Leckow – Barrington Research
Joe, a question for you. You have some time now to kind of analyze the market share data and talk about the -- from your comments I recognized that you have got some more information there about how our private label is doing? Obviously, the market seems to be shrinking, and I wondered if based upon the 4.4% prescription share growth, if you could talk about some other elements of that market share, and talk of the, sort of, friendly opportunity for us over the next three to five years because it seems to me that you are picking up quite a bit of market share and you are growing the size of the overall private label side of the business. I just wondered if you could help me frame the overall opportunity going forward?
Joe Capper
Yes, kind of a broad question. Let me see if I can address it in two different ways. First of all, the market is -- I think, at a macro level the market has experienced a lot pressure this year. I don’t think it’s necessary shrinking and I wouldn’t look at it that way. All the information we see clearly is that there is more and more people being diagnosed with diabetes everyday and there is no replacement, no cost-effective replacement clearly for measuring a blood sugar a couple of times a day. We believe this year that the level -- the market in generally has been affected by various swings, the least of which is, but not the least which is the economic conditions that people are making choices. If we look at how we are doing within that market, yes, I believe you are right. Clearly, we see ourselves gaining ground relative to our competitors, and I think a couple of things are working in our favor.
One, it’s a pretty mature market from a technology standpoint, and as we stated in our comments today, we believe for quite some time, that the TRUEtest platform was as good as anybody else’s out there. And now we have third-party validation and that’s exactly what puts -- what’s happening. And so people are probably moving more towards in the mature marketplace like this moving more towards the value opportunity, and that’s really our sweet spot. So, yes, we do see ourselves by gaining ground just from a consumer demand standpoint.
- To read the full transcript on Seeking Alpha, click here »
